neuroendocrine carcinoma
Showing 1 - 25 of 55
Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Zhengzhou (ZG006)
Not yet recruiting
- Small Cell Lung Cancer
- Neuroendocrine Carcinoma
- ZG006
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Aug 6, 2023
Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +18 more
- Clinical Encounter
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jul 24, 2023
Neuroendocrine Carcinoma Trial in Wuhan (Surufatinib and Serplulimab)
Not yet recruiting
- Neuroendocrine Carcinoma
- Surufatinib and Serplulimab
-
Wuhan, Hubei, ChinaCancer Center, Union Hospital, Tongji Medical College, Huazhong
Feb 18, 2023
GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)
Enrolling by invitation
- GEP-NET
- +3 more
-
Copenhagen, DenmarkRigshospitalet
Jan 24, 2023
Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Cancer Trial in Tampa (Pembrolizumab, Lenvatinib)
Active, not recruiting
- Neuroendocrine Tumors
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023
Breast Cancer, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, Injection of hyperpolarized
Enrolling by invitation
- Breast Cancer
- +3 more
- 18F-FDG
- +2 more
-
Copenhagen, DenmarkRigshospitalet
Jan 18, 2023
Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Chiba, Tokyo (RO7616789, Tocilizumab)
Recruiting
- Small Cell Lung Cancer
- Neuroendocrine Carcinoma
-
Chiba, Japan
- +1 more
Jan 16, 2023
Oncology, Neuroendocrine Carcinoma Trial in United Kingdom (Liposomal Irinotecan, Fluorouracil, Folinic Acid)
Active, not recruiting
- Oncology
- Neuroendocrine Carcinoma
- Liposomal Irinotecan
- +3 more
-
Glasgow, United Kingdom
- +3 more
Dec 2, 2022
Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)
Completed
- Melanoma
- +27 more
- XmAb20717
-
Los Angeles, California
- +16 more
Nov 29, 2022
Neuroendocrine Tumor Grade 3, Neuroendocrine Carcinoma, Pancreatic Carcinoma Trial in Tianjin (Surufatinib, Sintilimab)
Recruiting
- Neuroendocrine Tumor Grade 3
- +2 more
-
Tianjin, Tianjin, ChinaRui Liu
Nov 17, 2022
Solid Tumor, Non Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Rochester (VSV-IFNß-NIS, Pembrolizumab)
Recruiting
- Solid Tumor
- +2 more
- VSV-IFNβ-NIS
- Pembrolizumab
-
Rochester, MinnesotaMayo Clinic
Sep 26, 2022
Neuroendocrine Tumors - Patient Reported Outcomes
Enrolling by invitation
- Neuroendocrine Tumors
- +3 more
-
Gainesville, Florida
- +13 more
Jul 7, 2022
Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Germany (Cabozantinib)
Recruiting
- Neuroendocrine Tumors
- Neuroendocrine Carcinoma
-
Göttingen, Lower Saxony, Germany
- +5 more
Jun 27, 2022
Small-cell Lung Cancer, Neuroendocrine Carcinoma Trial (Iadademstat, Paclitaxel)
Not yet recruiting
- Small-cell Lung Cancer
- Neuroendocrine Carcinoma
- (no location specified)
Jun 13, 2022
Neuroendocrine Carcinoma Trial in London (Lu-DOTA-TATE)
Active, not recruiting
- Neuroendocrine Carcinoma
- Lu-DOTA-TATE
-
London, Ontario, CanadaLondon Health Sciences Centre
Apr 5, 2022
Neuroendocrine Carcinoma Trial in France (Nivolumab, Ipilimumab)
Active, not recruiting
- Neuroendocrine Carcinoma
-
Aix-en-Provence, France
- +6 more
Mar 9, 2022
Lung Atypical Carcinoid Tumor, Lung Neuroendocrine Tumor, Lung Non-Small Cell Squamous Carcinoma Trial in Conroe, Houston
Recruiting
- Lung Atypical Carcinoid Tumor
- +13 more
- Nivolumab
- Stereotactic Body Radiation Therapy
-
Conroe, Texas
- +2 more
Feb 25, 2022
Neuroendocrine Tumors, Neuroendocrine Carcinoma, Pancreas Tumor Trial in Roma, Rome (EUS guided radiofrequency ablation)
Recruiting
- Neuroendocrine Tumors
- +3 more
- EUS guided radiofrequency ablation
-
Roma, RM, Italy
- +1 more
Feb 10, 2022
Neuroendocrine Tumors, Carcinoma, Small Cell Lung, Neuroendocrine Carcinoma Trial in United Kingdom, United States (PEN-221)
Completed
- Neuroendocrine Tumors
- +2 more
-
Fort Myers, Florida
- +12 more
Nov 16, 2021
Neuroendocrine Tumors, Neuroendocrine Tumor Grade 3, Neuroendocrine Carcinoma Trial in Xiamen, Harbin (Chidamide, Sintilimab)
Recruiting
- Neuroendocrine Tumors
- +3 more
-
Xiamen, Fujian, China
- +1 more
Nov 22, 2021
Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Beijing, Xiamen, Harbin (Chidamide, Etoposide + Cisplatin/Carboplatin)
Recruiting
- Neuroendocrine Tumors
- Neuroendocrine Carcinoma
- Chidamide
- Etoposide + Cisplatin/Carboplatin
-
Beijing, Beijing, China
- +2 more
Nov 2, 2021
Lung Small Cell Carcinoma, Neuroendocrine Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Dostarlimab, Niraparib)
Recruiting
- Lung Small Cell Carcinoma
- +5 more
- Dostarlimab
- Niraparib
-
Houston, TexasM D Anderson Cancer Center
Sep 30, 2021
Neuroendocrine Carcinoma, Digestive Cancer Trial in France (Neoadjuvant treatment, Adjuvant treatment)
Recruiting
- Neuroendocrine Carcinoma
- Digestive Cancer
- Neoadjuvant treatment
- Adjuvant treatment
-
Amiens, France
- +13 more
Jun 10, 2021
Neuroendocrine Carcinoma Trial in Los Angeles (68Ga-DOTATATE)
Completed
- Neuroendocrine Carcinoma
-
Los Angeles, CaliforniaUniversity of California Los Angeles, Nuclear Medicine Clinic of
May 12, 2021